Arsil%25252525252525252525252520dx

# Arsil-DX (Dextromethorphan/Chlorpheniramine) ## Overview Arsil-DX is a multicomponent combination medication containing a cough suppressant (dextromethorphan) and a first-generation antihistamine (chlorpheniramine). It is primarily used for the symptomatic relief of cough and upper respiratory symptoms associated with the common cold or allergic rhinitis. ## Primary Indications Symptomatic relief of cough, sneezing, rhinorrhea, and lacrimation due to the common cold or seasonal allergies. ## Adult Dosing Standard formulation (e.g., 10 mg dextromethorphan / 2 mg chlorpheniramine per 5 mL): 10 mL orally every 4 to 6 hours as needed. **Maximum:** Do not exceed 40 mL (8 doses) in 24 hours. ## Pediatric Dosing **Children 6 to 12 years:** 5 mL orally every 4 to 6 hours. Maximum: 20 mL/24 hours. **Children <6 years:** Routine use is generally discouraged. Consult a pediatrician or local protocol due to narrow therapeutic index and risk of sedation. Do not use in children <4 years without explicit medical oversight. ## Dose Adjustments * **Renal/Hepatic Impairment:** No specific manufacturer guidelines; use caution and consider longer dosing intervals due to potential accumulation of antihistamine metabolites. * **Geriatrics:** Start at the lowest effective dose due to increased risk of anticholinergic side effects (e.g., urinary retention, confusion, falls). ## Contraindications * Hypersensitivity to dextromethorphan or chlorpheniramine. * Concurrent use (or use within 14 days) of Monoamine Oxidase Inhibitors (MAOIs). * Narrow-angle glaucoma, symptomatic prostatic hypertrophy, or bladder neck obstruction. * Severe asthma or lower respiratory tract symptoms. ## Adverse Effects * **Anticholinergic:** Xerostomia (dry mouth), blurred vision, urinary retention, constipation, tachycardia. * **CNS:** Significant drowsiness, dizziness, incoordination, paradoxical excitation (more common in children). * **GI:** Nausea and abdominal pain. ## Key Drug Interactions * **MAOIs:** Risk of serotonin syndrome or hypertensive crisis. * **CNS Depressants:** Alcohol, benzodiazepines, and opioids increase sedation and risk of respiratory depression. * **Other Anticholinergics:** Synergistic effects increase risk of cognitive impairment and adverse anticholinergic events. * **CYP2D6 Inhibitors:** May increase plasma concentrations of dextromethorphan. ## Monitoring * Monitor for excessive sedation or respiratory distress. * Monitor urinary output, especially in elderly patients with BPH. * Assess frequency of cough; if symptoms persist >7 days or are accompanied by high fever or rash, seek medical evaluation. ## Clinical Pearls * **Sedation Warning:** Must warn patients about driving or operating heavy machinery. * **Avoid Double Dosing:** Ensure patients are not taking other OTC cough/cold medications containing these same active ingredients to avoid toxicity. * **Dextromethorphan:** While generally safe at therapeutic doses, it has abuse potential (dissociative effects at supratherapeutic levels). *** **Educational Disclaimer:** This information is for educational purposes only. Always verify clinical dosing, indications, and contraindications against institutional protocols and the most current prescribing information (e.g., FDA labels or clinical pharmacology databases). Assess individual patient factors, including allergies and comorbidities, before recommending or prescribing.